GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for polyribonucleotide nucleotidyltransferase (B1I393)

Analyse AlphaFold monomer V2.0 prediction for polyribonucleotide nucleotidyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B1I393
Type
protein
Length
741 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x429aA010A80A47FF4a2777bB34A2bba144d19df2
Molecule
Polyribonucleotide nucleotidyltransferase
UniProt
B1I393
Pockets
4 · best druggability 0.79

Structure

1 distinct chain · 34% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APolyribonucleotide nucleotidyltransferaseprotein74134% helix, 28% strandB1I393

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19040.790.8175empty
28300.690.7682empty
3580.360.7812empty
4590.260.7315empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.